Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma

Published:2010-06 Issue:3 Volume:10 Page:186-191
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Rifkin Robert,Spitzer Gary,Orloff Gregory,Mandanas Romeo,McGaughey Dean,Zhan Feng,Boehm Kristi A.,Asmar Lina,Beveridge Roy

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference11 articles.

1. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels;Criteria Committee of the New York Heart Association,1994

2. Neulasta (Pegfilgrastim) Prescribing Information;Amgen, Inc.,2008

3. Pegfilgrastim: the promise of pegylation fulfilled;Crawford;Ann Oncol,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022;International Journal of Clinical Oncology;2024-04-23

2. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: A systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022;2024-01-12

3. Optimizing Granulocyte Colony-Stimulating Factor Transcript for Enhanced Expression in Escherichia coli;Frontiers in Bioengineering and Biotechnology;2021-03-09

4. Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation;Hematology;2021-01-01

5. A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant;Annals of Hematology;2019-12-18